Citation: | WANG Yunshan, WANG Jie, WANG Xiaonan, JIANG Cuihua, ZHENG Xian, ZHANG Jian, YIN Zhiqi. Therapeutic effects of gypenosides on hypercholesterolemia and it protective effect on liver injury[J]. Journal of China Pharmaceutical University, 2021, 52(1): 84-91. DOI: 10.11665/j.issn.1000-5048.20210112 |
[1] |
. Clin Ther, 2016, 38(7): 1696-1709.
|
[2] |
Bj?rnsson E, Jacobsen EI, Kalaitzakis E. Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing[J]. J Hepatol, 2012, 56(2): 374-380.
|
[3] |
Hazen SL. New lipid and lipoprotein targets for the treatment of cardiometabolic diseases[J]. J Lipid Res, 2012, 53(9): 1719-1721.
|
[4] |
Chen SK. A classificatory system and geographical distribution of the genus Gynostemma BL[J]. Acta Phytotaxon Sin(植物分类学报), 1995,33(4): 403-410.
|
[5] |
Jeenduang N, Sangkaew B, Chantaracha P, et al. APOE and CETP TaqIB polymorphisms influence metabolic responses to Hibiscus sabdariffa L. and Gynostemma pentaphyllum Makino tea consumption in hypercholesterolemic subjects[J]. Asia Pac J Clin Nutr, 2017, 26(2): 368-378.
|
[6] |
Zhang YD, Jiang XY, Cao LJ, et al. Gypenoside granules improved lipid metabolism in C57BL/6J mice with hyperlipidemia[J]. J China Pharm Univ(中国药科大学学报), 2019, 50(6): 713-720.
|
[7] |
Wu LS, Qian MZ. Effects of gypenosides on PCSK9 gene expression and blood lipids lowered by simvastatin[J]. Chin J Pathol(中华病理学杂志), 2017, 33(1): 79-85.
|
[8] |
Shen TT, Hua EB, Ma N, et al. Effects of phlorizin on hepatic cholesterol metabolism genes expression in hamsters fed high fat and cholesterol diet[J]. Acta Nutr Sin(营养学报), 2014, 36(2): 159-163.
|
[9] |
Dong B, Wu MH, Li H, et al. Strong induction of PCSK9 gene expression through HNF1α and SREBP2: mechanism for the resistance to LDL-cholesterol lowering effect of statins in dyslipidemic hamsters[J]. J Lipid Res, 2010, 51(6): 1486-1495.
|
[10] |
Li HS, Ying H, Hu AR, et al. Therapeutic effect of gypenosides on nonalcoholic steatohepatitis via regulating hepatic lipogenesis and fatty acid oxidation[J]. Biol Pharm Bull, 2017, 40(5): 650-657.
|
[11] |
Chen JX. Study on liver-protective effect of total saponins of Gynostemma pentaphyllum[J]. China Pharm(中国药业), 2007, 16(13): 7-8.
|
[12] |
Armitage J, Bowman L, Collins R, et al. Effects of simvastatin 40 mg daily on muscle and liver adverse effects in a 5-year randomized placebo-controlled trial in 20, 536 high-risk people[J]. BMC Clin Pharmacol, 2009, 31(9): 6.
|
[13] |
Kanasaki A, Jiang Z, Mizokami T, et al. Dietary D-allulose alters cholesterol metabolism in Golden Syrian hamsters partly by reducing serum PCSK9 levels[J]. J Funct Foods, 2019, 60: 103429-103429.
|
[14] |
Kang ZY, Chu XX, Yang RM, et al. Study on the biomarkers of cholesterol metabolic disorder in hyperlipemia model of golden hamster[J]. Chin Pharmacol Bull(药学通报), 2014, 30(6): 880-883.
|
[15] |
Madsen CS, Janovitz E, Zhang R, et al. The guinea pig as a preclinical model for demonstrating the efficacy and safety of statins[J]. J Pharmacol Exp Ther, 2008, 324(2): 576-586.
|
[16] |
Ito BR, Zhang BH, Cable EE, et al. Thyroid hormone beta receptor activation has additive cholesterol lowering activity in combination with atorvastatin in rabbits, dogs and monkeys[J]. Br J Pharmacol, 2009, 156(3): 454-465.
|
[17] |
Pel P, Chae HS, Nhoek P, et al. Chemical constituents with proprotein convertase subtilisin/kexin type 9 mRNA expression inhibitory activity from dried immature Morus alba fruits[J]. J Agric Food Chem, 2017, 65(26): 5316-5321.
|